BTMD
BTMD
NASDAQ · Pharmaceuticals

Biote Corp -A

$1.36
+0.01 (+0.74%)
As of Sep 20, 10:46 PM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 9 82%
Hold 2 18%
Sell 0 0%
Price Target
Analyst Price Target +1,128.7% upside
Low Target $12.81
Average Target $16.71
High Target $20.08
Current Price $1.36
Current
$1.36
Target
$16.71
$12.81 $16.71 avg $20.08
Scenario Analysis
Bear Case
$12.81
841.9%
Low target
Base Case
$16.71
+1,128.7%
Avg target
Bull Case
$20.08
+1,376.5%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$3.52
-61.4% from high
52-Week Low
$1.27
+7.1% from low
Target vs 52W High
$16.71
+374.7% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +13.7%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.3%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +5.5%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +21.4%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +180.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +188.0%